RecallDepth
Class III Terminated

Clofarabine injection, 20 mg/20 mL, 20 mL Single-Use Vial, Rx only, Mfd by: Teva Pharmachemle, Swensweg 5, Haarlem, The Netherlands; Mfd for: Winthrop U.S., a business of sanofi-aventis U.S. LLC, Bridgewater, NJ 08807; NDC 0955-1746-01.

Company
Sanofi-Aventis U.S. Llc
Recall Initiated
October 13, 2017
Posted
November 8, 2017
Recall Number
D-0056-2018
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
422 vials
Firm Location
Bridgewater, NJ, United States

Reason for Recall

Labeling: Incorrect or Missing Package Insert: authorized generic product was packaged with the incorrect insert for the brand name product Clolar (clofarabine) injection.

Distribution

Nationwide in the USA

Lot / Code Info

Lot #: K5006Y02, Exp 31AUG18

More recalls by Sanofi-Aventis U.S. Llc

View all recalls by this company →

Other recent Class III Drug recalls